Insider · CIK 0001044831

BAKER DARRYL S

Reports to the SEC for 3 companies · SCOTTSDALE, AZ

sec.gov

Transactions

Companies

Filings

CIK

0001044831

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+14K sh	—	—	14,000
2017-02-21	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+56K sh	—	—	56,000
2016-11-10	Insys Therapeutics, Inc.G Gift	Chief Financial Officer	GGift	−4,000 sh	—	—	18,312
2016-05-23	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	80,000
2016-05-23	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$13.57	+$136K	21,030
2016-05-02	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2015-11-20	Insys Therapeutics, Inc.G Gift	Chief Financial Officer	GGift	−9,000 sh	—	—	11,030
2015-05-18	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−6,000 sh	$59.40	−$356K	13,377
2015-05-18	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,000 sh	$58.83	−$235K	9,377
2015-05-05	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2015-02-09	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,752 sh	—	—	110,000
2015-02-09	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,752 sh	$7.26	+$63.5K	28,129
2015-02-09	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−8,752 sh	$52.18	−$457K	19,377
2015-02-06	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15K sh	$2.36	+$35.4K	34,377
2015-02-06	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,248 sh	—	—	118,752
2015-02-06	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−6,248 sh	$52.25	−$326K	19,377
2015-02-06	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	60,000
2015-02-06	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,248 sh	$7.26	+$45.4K	40,625
2015-02-06	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$52.25	−$784K	25,625
2014-08-07	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2014-01-16	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$10.89	+$109K	13,125
2014-01-16	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$50.17	−$251K	3,125
2014-01-16	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	90,000
2014-01-16	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$49.05	−$245K	8,125
2014-01-15	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	50,000
2014-01-15	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$3.54	+$17.7K	8,125
2014-01-15	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$48.01	−$240K	3,125
2014-01-14	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,083 sh	—	—	60,000
2014-01-14	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$3.54	+$17.7K	8,125
2014-01-14	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$47.07	−$235K	3,125
2014-01-14	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	55,000
2014-01-14	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,083 sh	$46.01	−$188K	3,125
2014-01-14	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,083 sh	$3.54	+$14.5K	7,208
2014-01-13	Insys Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,917 sh	$3.54	+$20.9K	9,042
2014-01-13	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$45.25	−$226K	4,042
2014-01-13	Insys Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−917 sh	$46.04	−$42.2K	3,125
2014-01-13	Insys Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,917 sh	—	—	64,083
2013-05-14	Insys Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2012-04-28	iGo, Inc.F Tax Payment	Chief Financial Officer, Vice President	FTax Payment	−6,670 sh	$0.75	−$5,002.5	173,393
2012-04-10	iGo, Inc.Stock OptionA Award	Chief Financial Officer, Vice President	AAward	+210K sh	$0.75	+$158K	210,000
2012-03-19	iGo, Inc.F Tax Payment	Chief Financial Officer, Vice President	FTax Payment	−10.4K sh	$0.65	−$6,774.3	180,063
2011-04-28	iGo, Inc.M Exercise/Conversion	Chief Financial Officer, Vice President	MExercise/Conversion	+60K sh	—	—	190,485
2011-03-19	iGo, Inc.F Tax Payment	Chief Financial Officer, Vice President	FTax Payment	−9,109 sh	$2.83	−$25.8K	130,485
2011-01-02	iGo, Inc.F Tax Payment	Chief Financial Officer, Vice President	FTax Payment	−1,932 sh	$3.84	−$7,418.88	139,485
2011-01-02	iGo, Inc.F Tax Payment	Chief Financial Officer, Vice President	FTax Payment	−1,823 sh	$3.84	−$7,000.32	139,594
2010-11-03	iGo, Inc.S Sale	Chief Financial Officer, Vice President	SSale	−3,364 sh	$2.01	−$6,761.64	141,417
2010-11-03	iGo, Inc.S Sale	Chief Financial Officer, Vice President	SSale	−5,000 sh	$2.00	−$10K	147,281
2010-11-03	iGo, Inc.S Sale	Chief Financial Officer, Vice President	SSale	−2,500 sh	$2.02	−$5,050	144,781
2010-09-23	iGo, Inc.S Sale	Chief Financial Officer, Vice President	SSale	−14.1K sh	$2.00	−$28.3K	152,281
2010-08-03	iGo, Inc.S Sale	Chief Financial Officer, Vice President	SSale	−22K sh	$1.75	−$38.5K	166,417

Recent filings

Accepted (ET)
Feb 234
Insys Therapeutics, Inc.0001209191-17-014090
SEC(opens sec.gov)
Jan 175
Insys Therapeutics, Inc.0001209191-17-003975
SEC(opens sec.gov)
May 234
Insys Therapeutics, Inc.0001209191-16-122639
SEC(opens sec.gov)
May 44
Insys Therapeutics, Inc.0001209191-16-117572
SEC(opens sec.gov)
Jan 225
Insys Therapeutics, Inc.0001209191-16-093244
SEC(opens sec.gov)
May 184
Insys Therapeutics, Inc.0001209191-15-043709
SEC(opens sec.gov)
May 74
Insys Therapeutics, Inc.0001209191-15-039914
SEC(opens sec.gov)
Feb 104
Insys Therapeutics, Inc.0001209191-15-011381
SEC(opens sec.gov)
Aug 114
Insys Therapeutics, Inc.0001209191-14-051646
SEC(opens sec.gov)

Companies

Address

17800 N. PERIMETER DRIVE SUITE 200

SCOTTSDALE, AZ, 85255